• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寄生虫线粒体作为药物靶点:生命周期中的多样性与动态变化

Parasite mitochondria as drug target: diversity and dynamic changes during the life cycle.

作者信息

Kita Kiyoshi, Nihei Coichi, Tomitsuka Eriko

机构信息

Department of Biomedical Chemistry, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

出版信息

Curr Med Chem. 2003 Dec;10(23):2535-48. doi: 10.2174/0929867033456549.

DOI:10.2174/0929867033456549
PMID:14529469
Abstract

Parasites have developed a wide variety of physiological functions to survive within the specialized environments of the host. Regarding energy metabolism, which represents an essential factor for survival, parasites adapt low oxygen tension in host mammals using metabolic systems that differ substantially from those of the host. Most parasites do not use free oxygen available within the host, but employ systems other than oxidative phosphorylation for ATP synthesis. Furthermore, parasites display marked changes in mitochondrial morphology and components during the life cycle, and these represent very interesting elements of biological processes such as developmental control and environmental adaptation. The enzymes in parasite-specific pathways offer potential targets for chemotherapy. Cyanide-insensitive trypanosome alternative oxidase (TAO) is the terminal oxidase of the respiratory chain of long slender bloodstream forms of the African trypanosome, which causes sleeping sickness. Recently, the most potent inhibitor of TAO to date, ascofuranone, was isolated from the phytopathogenic fungus, Ascochyta visiae. The inhibitory mechanisms of ascofuranone have been revealed using recombinant enzyme. Parasite-specific respiratory systems are also found in helminths. The NADH-fumarate reductase system in mitochondria form a final step in the phosphoenolpyruvate carboxykinase (PEPCK)-succinate pathway, which plays an important role in anaerobic energy metabolism for the Ascaris suum adult. Enzymes in this system, such as NADH-rhodoquinone reductase (complex I) and rhodoquinol-fumarate reductase (complex II), form promising targets for chemotherapy. In fact, a specific inhibitor of nematode complex I, nafuredin, has been found in mass-screening using parasite mitochondria.

摘要

寄生虫已发展出多种多样的生理功能,以便在宿主的特殊环境中生存。关于能量代谢这一生存的关键因素,寄生虫利用与宿主截然不同的代谢系统来适应宿主哺乳动物体内的低氧张力。大多数寄生虫不利用宿主体内的游离氧,而是采用氧化磷酸化以外的系统来合成ATP。此外,寄生虫在生命周期中,线粒体的形态和组成会发生显著变化,这些代表了生物过程中非常有趣的元素,如发育控制和环境适应。寄生虫特异性途径中的酶为化疗提供了潜在靶点。对氰化物不敏感的锥虫替代氧化酶(TAO)是非洲锥虫长细血流形式呼吸链的末端氧化酶,非洲锥虫会引发昏睡病。最近,从植物病原真菌葡萄座腔菌中分离出了迄今为止最有效的TAO抑制剂——阿斯科呋喃酮。已利用重组酶揭示了阿斯科呋喃酮的抑制机制。在蠕虫中也发现了寄生虫特异性的呼吸系统。线粒体中的NADH - 延胡索酸还原酶系统是磷酸烯醇丙酮酸羧激酶(PEPCK) - 琥珀酸途径的最后一步,该途径在猪蛔虫成虫的无氧能量代谢中起重要作用。该系统中的酶,如NADH - 玫红醌还原酶(复合体I)和玫红醇 - 延胡索酸还原酶(复合体II),是很有前景的化疗靶点。事实上,在利用寄生虫线粒体进行的大规模筛选中,已发现了线虫复合体I的特异性抑制剂萘呋地定。

相似文献

1
Parasite mitochondria as drug target: diversity and dynamic changes during the life cycle.寄生虫线粒体作为药物靶点:生命周期中的多样性与动态变化
Curr Med Chem. 2003 Dec;10(23):2535-48. doi: 10.2174/0929867033456549.
2
Trypanosome alternative oxidase as a target of chemotherapy.锥虫交替氧化酶作为化疗靶点
Biochim Biophys Acta. 2002 Jul 18;1587(2-3):234-9. doi: 10.1016/s0925-4439(02)00086-8.
3
Role of complex II in anaerobic respiration of the parasite mitochondria from Ascaris suum and Plasmodium falciparum.复合物II在猪蛔虫和恶性疟原虫寄生虫线粒体无氧呼吸中的作用。
Biochim Biophys Acta. 2002 Jan 17;1553(1-2):123-39. doi: 10.1016/s0005-2728(01)00237-7.
4
Electron-transfer complexes in Ascaris mitochondria.蛔虫线粒体中的电子传递复合物。
Adv Parasitol. 2002;51:95-131. doi: 10.1016/s0065-308x(02)51004-6.
5
Mitochondrial fumarate reductase as a target of chemotherapy: from parasites to cancer cells.线粒体延胡索酸还原酶作为化疗靶点:从寄生虫到癌细胞
Biochim Biophys Acta. 2012 May;1820(5):643-51. doi: 10.1016/j.bbagen.2011.12.013. Epub 2011 Dec 29.
6
Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.锥虫交替氧化酶是昏睡病的一个潜在治疗靶点,在布氏锥虫亚种中保守存在。
Parasitol Int. 2010 Dec;59(4):560-4. doi: 10.1016/j.parint.2010.07.006. Epub 2010 Aug 3.
7
Functional expression of the ascofuranone-sensitive Trypanosoma brucei brucei alternative oxidase in the cytoplasmic membrane of Escherichia coli.抗阿糖呋喃酮的布氏布氏锥虫交替氧化酶在大肠杆菌细胞质膜中的功能表达。
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1999 Oct;124(2):141-8. doi: 10.1016/s0742-8413(99)00040-7.
8
Overproduction of highly active trypanosome alternative oxidase in Escherichia coli heme-deficient mutant.在大肠杆菌血红素缺陷型突变体中高效表达锥虫交替氧化酶。
Parasitol Int. 2003 Sep;52(3):237-41. doi: 10.1016/s1383-5769(03)00007-2.
9
Pharmacophore identification of ascofuranone, potent inhibitor of cyanide-insensitive alternative oxidase of Trypanosoma brucei.阿朴啡酮的药效团鉴定,一种有效的新型克氏锥虫氰化物不敏感交替氧化酶抑制剂。
J Biochem. 2013 Mar;153(3):267-73. doi: 10.1093/jb/mvs135. Epub 2012 Nov 23.
10
Strain-specific difference in amino acid sequences of trypanosome alternative oxidase.锥虫交替氧化酶氨基酸序列的种株特异性差异
Parasitol Int. 2002 Jun;51(2):195-9. doi: 10.1016/s1383-5769(02)00010-7.

引用本文的文献

1
Identification of a family of species-selective complex I inhibitors as potential anthelmintics.鉴定一组具有物种选择性的复合物 I 抑制剂,作为潜在的驱虫药物。
Nat Commun. 2024 May 8;15(1):3367. doi: 10.1038/s41467-024-47331-3.
2
Multi-omics data elucidate parasite-host-microbiota interactions and resistance to Haemonchus contortus in sheep.多组学数据阐明了寄生虫-宿主-微生物群相互作用以及绵羊对捻转血矛线虫的抗性。
Parasit Vectors. 2024 Mar 1;17(1):102. doi: 10.1186/s13071-024-06205-9.
3
Fumarate respiration of flukes as a potential drug target.
作为潜在药物靶点的吸虫的延胡索酸呼吸。
Front Cell Infect Microbiol. 2024 Jan 25;13:1302114. doi: 10.3389/fcimb.2023.1302114. eCollection 2023.
4
A Comprehensive Review on the Roles of Metals Mediating Insect-Microbial Pathogen Interactions.关于金属介导昆虫与微生物病原体相互作用的作用的综合综述
Metabolites. 2023 Jul 11;13(7):839. doi: 10.3390/metabo13070839.
5
Dual inhibition of the energy metabolism.能量代谢的双重抑制
Front Vet Sci. 2022 Aug 5;9:981664. doi: 10.3389/fvets.2022.981664. eCollection 2022.
6
Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens.米托坦再利用:新型抗癌候选药物对主要原生动物和真菌病原体表现出强大的活性。
Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0072722. doi: 10.1128/aac.00727-22. Epub 2022 Jul 20.
7
Evolutionary Adaptations of Parasitic Flatworms to Different Oxygen Tensions.寄生扁虫对不同氧张力的进化适应性
Antioxidants (Basel). 2022 May 31;11(6):1102. doi: 10.3390/antiox11061102.
8
Identification of enzymes that have helminth-specific active sites and are required for Rhodoquinone-dependent metabolism as targets for new anthelmintics.鉴定具有寄生虫特异性活性位点且对 Rhodoquinone 依赖性代谢必需的酶作为新驱虫药的靶标。
PLoS Negl Trop Dis. 2021 Nov 29;15(11):e0009991. doi: 10.1371/journal.pntd.0009991. eCollection 2021 Nov.
9
Alternative splicing of controls the levels of rhodoquinone in animals.可变剪接调控动物体内的 Rho 醌水平。
Elife. 2020 Aug 3;9:e56376. doi: 10.7554/eLife.56376.
10
Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.药物再利用应用:抗疟药甲氟喹对泡球蚴的活性。
Int J Parasitol Drugs Drug Resist. 2020 Aug;13:121-129. doi: 10.1016/j.ijpddr.2020.06.002. Epub 2020 Jul 2.